Capsugel targets nutra and pharma sectors with liquid lipid technology

- Last updated on GMT

Related tags: Pharmacology

Capsugel targets nutra and pharma with liquid lipid tek
Pharma and supplement manufacturing giant Capsugel has launched a platform around lipids, liquids and semi-solid fill technologies targeting the food supplement and pharma sectors.

Its Lipidex initiative will accelerate its Dosage Form Solutions (DFS) business, the company said, with “tailored solutions of low solubility drugs in their pipeline, repositioning existing drugs for better therapeutic performance or rebranding them using innovative dosage forms,” ​said Amit Patel, president, Capsugel DFS.

“Through Capsugel’s historical investments and our recent acquisition of Encap Drug Delivery, the LIPIDEX platform represents the industry’s most comprehensive and vertically integrated offering in the lipid, liquid and semi-solid arena.  It spans polymer science and process engineering at the capsule level, as well as API handling, dosage formulation development using expert systems, clinical trial quantity supply and commercial manufacturing.”

The platform will be run out of its manufacturing sites in the US, Europe and Japan. 

Related topics: Suppliers

Related news

Follow us

Products

View more

Webinars